Apollo Hospitals Jumps 5.3%: Macquarie Double Upgrade
🏥 Hospital stocks in focus! APOLLOHOSP closed 5.29% higher at ₹9,200 on 20 Nov 2026 and touched a fresh 52-week high, after Macquarie upgraded the stock two notches, from Underperform to Outperform. Max Healthcare (+3.88%) and Narayana Hrudayalaya also moved up. In this opinion, I break down: ✅ Why Macquarie skipped "Neutral" and went straight to Outperform ✅ Reason 1: Earnings estimates appear to have bottomed out and stabilised ✅ Reason 2: New hospital beds are filling up, with utilisation expected to keep improving ✅ Reason 3: Valuation concerns have eased; the early profit drag from new capacity looks largely priced in ✅ Key risks flagged: wider drug price controls, slower ramp-up of new hospitals, and rising costs in the 24/7 pharmacy (HealthCo) segment ✅ What investors can track next: occupancy, revenue per bed and margins in coming quarters The rally came on a strong day for markets, with Nifty up 1.12% to 25,800.60 and FIIs net buyers. 💬 Is India's hospital sector entering a new growth phase, or is the good news already in the price? Share your view in the comments! 📲 For daily market notes, search "Neha Gupta SEBI RA" on Telegram and join the FREE channel. Neha Gupta | SEBI Registered Research Analyst | Reg. No. INH000016542 ⚠️ Disclaimer: This content is for educational purposes only and is not investment advice or a buy/sell recommendation. Investments in the securities market are subject to market risks. Read all related documents carefully before investing.



















